Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:44 pm Sale | 2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 10,412,872 5.600% | -4,031,572 (-27.91%) | Filing History |
| 2024-02-14 8:42 pm Purchase | 2023-12-31 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III, L.P. | 3,395,606 6.500% | 912,000 (+36.72%) | Filing History |
| 2024-02-14 8:38 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 4,497,117 7.300% | 789,226 (+21.29%) | Filing History |
| 2024-02-14 8:28 pm Purchase | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III, L.P. | 5,555,568 9.990% | 1,324,947 (+31.32%) | Filing History |
| 2024-02-14 8:28 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners III, L.P. | 2,476,980 9.990% | 2,476,980 (New Position) | Filing History |
| 2024-02-14 8:26 pm Purchase | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 1,556,421 7.500% | 966,472 (+163.82%) | Filing History |
| 2024-02-14 8:26 pm Purchase | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Venrock Healthcare Capital Partners III, L.P. | 2,070,000 3.300% | 2,070,000 (New Position) | Filing History |
| 2024-02-14 8:25 pm Purchase | 2023-12-31 | 13G | Abivax S.A. ABVX | Venrock Healthcare Capital Partners III, L.P. | 3,611,570 5.700% | 298,570 (+9.01%) | Filing History |
| 2024-02-01 4:15 pm Purchase | 2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,428,385 6.600% | 4,428,385 (New Position) | Filing History |
| 2024-01-02 4:16 pm Purchase | 2023-12-21 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 3,225,806 8.900% | 3,225,806 (New Position) | Filing History |
| 2023-12-28 4:17 pm Purchase | 2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 7,775,760 6.800% | 7,775,760 (New Position) | Filing History |
| 2023-12-28 4:16 pm Purchase | 2023-12-26 | 13G | KalVista Pharmaceuticals, Inc. KALV | Venrock Healthcare Capital Partners III, L.P. | 3,573,714 10.300% | 657,047 (+22.53%) | Filing History |
| 2023-11-30 4:15 pm Purchase | 2023-11-20 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III, L.P. | 2,483,606 6.100% | 2,483,606 (New Position) | Filing History |
| 2023-11-22 4:16 pm Purchase | 2023-10-24 | 13G | Abivax S.A. ABVX | Venrock Healthcare Capital Partners III, L.P. | 3,313,000 5.300% | 3,313,000 (New Position) | Filing History |
| 2023-09-29 4:15 pm Purchase | 2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB | Venrock Healthcare Capital Partners III, L.P. | 4,016,847 6.600% | 4,016,847 (New Position) | Filing History |
| 2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 927,706 6.300% | 927,706 (New Position) | Filing History |
| 2023-08-28 4:16 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 14,444,444 7.700% | 14,444,444 (New Position) | Filing History |
| 2023-08-07 4:15 pm Purchase | 2023-07-28 | 13G | Mersana Therapeutics, Inc. MRSN | Venrock Healthcare Capital Partners III, L.P. | 387,120 8.500% | 387,120 (New Position) | Filing History |
| 2023-07-28 4:15 pm Purchase | 2023-07-18 | 13D | Apogee Therapeutics, Inc. APGE | Venrock Healthcare Capital Partners III, L.P. | 3,887,478 9.990% | 3,887,478 (New Position) | Filing History |
| 2023-07-24 4:16 pm Purchase | 2023-07-14 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 589,949 5.900% | 589,949 (New Position) | Filing History |